Provider QP33-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Strensiq (asfotase alfa) Read More
Provider QP9-18 New Drug-Related Pharmacy Step Therapy (ST) Program Ophthalmic Antihistamine Read More
Provider QP18-18 Medical Drug Exclusion Lists Expanded to Include Ixifi, Durolane, Visco 3 and TriVisc Read More
